Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

11.4K
Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining,...
11.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Programmable Surface Catalyzed Heterogeneous Nucleation Enables "Double-Cable" Light-Harvesting Supramolecular Polymers.

Journal of the American Chemical Society·2026
Same author

Dopamine and Rotenone Modulate α-Synuclein Phase Separation and Liquid to Solid Transition.

Small (Weinheim an der Bergstrasse, Germany)·2026
Same author

Density transitions in the regulation of transcription.

Molecular cell·2026
Same author

Compaction of chromatin domains regulates target search times of proteins.

PLoS computational biology·2026
Same author

Protein aggregates and biomolecular condensates: implications for human health and disease.

Frontiers in molecular biosciences·2025
Same author

Organization principles of dynamic three-dimensional genome architecture associated with centromere clustering states.

Proceedings of the National Academy of Sciences of the United States of America·2025
Same journal

A rechargeable non-aqueous Mg-O<sub>2</sub> battery based on magnesium peroxide chemistry.

Nature chemistry·2026
Same journal

Setting a direction for molecular motors.

Nature chemistry·2026
Same journal

Driving movement in the field of molecular machines.

Nature chemistry·2026
Same journal

First ladies of chemistry.

Nature chemistry·2026
Same journal

How isoprene connects plants to global climate.

Nature chemistry·2026
Same journal

One-dimensional carbon chains free of end-capping groups.

Nature chemistry·2026
See all related articles

Related Experiment Video

Updated: Dec 18, 2025

Exogenous Administration of Microsomes-associated Alpha-synuclein Aggregates to Primary Neurons As a Powerful Cell Model of Fibrils Formation
09:16

Exogenous Administration of Microsomes-associated Alpha-synuclein Aggregates to Primary Neurons As a Powerful Cell Model of Fibrils Formation

Published on: June 26, 2018

7.9K

α-Synuclein aggregation nucleates through liquid-liquid phase separation.

Soumik Ray1, Nitu Singh1, Rakesh Kumar1

  • 1Department of Biosciences and Bioengineering, IIT Bombay, Mumbai, India.

Nature Chemistry
|June 10, 2020
PubMed
Summary
This summary is machine-generated.

Liquid-liquid phase separation of alpha-synuclein (α-Syn) precedes its aggregation in Parkinson's disease pathogenesis. This process, involving droplet formation and maturation, is promoted by disease-associated factors.

More Related Videos

Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains
09:27

Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains

Published on: January 5, 2016

17.9K
Author Spotlight: Evaluation of Protein-Condensate Dynamics in Live Human Cells
06:48

Author Spotlight: Evaluation of Protein-Condensate Dynamics in Live Human Cells

Published on: January 5, 2024

4.9K

Related Experiment Videos

Last Updated: Dec 18, 2025

Exogenous Administration of Microsomes-associated Alpha-synuclein Aggregates to Primary Neurons As a Powerful Cell Model of Fibrils Formation
09:16

Exogenous Administration of Microsomes-associated Alpha-synuclein Aggregates to Primary Neurons As a Powerful Cell Model of Fibrils Formation

Published on: June 26, 2018

7.9K
Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains
09:27

Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains

Published on: January 5, 2016

17.9K
Author Spotlight: Evaluation of Protein-Condensate Dynamics in Live Human Cells
06:48

Author Spotlight: Evaluation of Protein-Condensate Dynamics in Live Human Cells

Published on: January 5, 2024

4.9K

Area of Science:

  • Neuroscience
  • Biochemistry
  • Molecular Biology

Background:

  • Alpha-synuclein (α-Syn) aggregation is a key hallmark of Parkinson's disease (PD).
  • The initial steps driving α-Syn aggregation and amyloid formation remain incompletely understood.
  • Understanding early events is crucial for developing effective PD therapeutics.

Purpose of the Study:

  • To investigate the early events in α-Syn aggregation.
  • To determine if liquid-liquid phase separation (LLPS) precedes α-Syn aggregation.
  • To elucidate the role of LLPS in Parkinson's disease pathogenesis.

Main Methods:

  • In vitro reconstitution of α-Syn.
  • Cellular models of α-Syn aggregation.
  • Microscopy and biochemical assays to analyze α-Syn phase separation and aggregation.

Main Results:

  • Liquid-like droplets of α-Syn form in vitro and mature into amyloid hydrogels.
  • Factors exacerbating PD, including low pH and mutations, promote α-Syn LLPS.
  • Cellular α-Syn droplets form and mature into perinuclear aggresomes, regulated by microtubules.

Conclusions:

  • Liquid-liquid phase separation is an early, critical step in α-Syn aggregation.
  • LLPS of α-Syn is modulated by factors relevant to Parkinson's disease.
  • This study provides mechanistic insights into α-Syn pathogenesis and potential therapeutic targets.